Omalizumab in Chronic Inducible Urticaria: a Real-Life Study of Efficacy, Safety, Predictors of Treatment Outcome, Time to Response and Relapse

被引：0
|
作者：
Yu, Miao [1 ]
Maurer, Marcus [2 ]
Chen, Yudi [3 ]
Zhao, Zuotao [1 ]
机构：
[1] Peking Univ, Beijing, Peoples R China
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Beijing Hosp, Beijing, Peoples R China
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
083
引用
收藏
页码：AB26 / AB26
页数：1
相关论文
共 50 条
  • [41] Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation
    Bras, Rita
    Costa, Celia
    Limao, Rita
    Caldeira, Leonor Esteves
    Paulino, Marisa
    Pedro, Elisa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (08): : 2392 - 2402
  • [42] Omalizumab treatment in patients with severe chronic spontaneous urticaria: consideration from real-life experience in Italy
    Asero, Riccardo
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 : 1 - 2
  • [43] Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
    Calzari, Paolo
    Chiei Gallo, Alessandra
    Barei, Francesca
    Bono, Eleonora
    Cugno, Massimo
    Marzano, Angelo Valerio
    Ferrucci, Silvia Mariel
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [44] Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria
    Foti, Caterina
    Romita, Paolo
    Ambrogio, Francesca
    Fanelli, Margherita
    Panebianco, Rosanna
    Vena, Gino Antonio
    Cassano, Nicoletta
    Ragusa, Mariagrazia
    Giuffrida, Roberta
    Papaianni, Valeria
    Borgia, Francesco
    Cannavo, Serafinella Patrizia
    Guarneri, Fabrizio
    DERMATOLOGIC THERAPY, 2022, 35 (02)
  • [45] Analysis of the efficacy and safety of omalizumab in treatment of idiopathic chronic urticaria in Vietnam
    Khanh, B., V
    Nguyet, N. N.
    Phuong, N. H.
    Tu, T. T.
    Hieu, C. C.
    ALLERGY, 2017, 72 : 721 - 721
  • [46] Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice
    Labrador-Horrillo, Moises
    Valero, Antonio
    Velasco, Manuel
    Jauregui, Ignacio
    Sastre, Joaquin
    Bartra, Joan
    Francisco Silvestre, Juan
    Ortiz de Frutos, Javier
    Gimenez-Arnau, Ana
    Ferrer, Marta
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1225 - 1228
  • [47] Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America
    Cherrez-Ojeda, Ivan
    Maurer, Marcus
    Bernstein, Jonathan A.
    Vanegas, Emanuel
    Felix, Miguel
    Ramon, German D.
    Ensina, Luis Felipe
    Larco Sousa, Jose Ignacio
    Matos Benavides, Edgar Emilio
    Cardona Villa, R.
    Staffeld, P. Latour
    Maria Morfin-Maciel, Blanca
    Mori, Jose
    Wilches C, Paul
    Mata, Valeria L.
    Cherrez, Annia
    WORLD ALLERGY ORGANIZATION JOURNAL, 2019, 12 (02):
  • [48] Omalizumab in chronic spontaneous urticaria A real-life experience of dose and intervals adjustments in Belgium
    de Montjoye, Laurence
    Herman, Anne
    Dumoutier, Laure
    Lambert, Michel
    Tromme, Isabelle
    Baeck, Marie
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : 620 - 622
  • [49] Chronic spontaneous urticaria treated with omalizumab: Real-life data from a tertiary center
    Araujo, M.
    Goncalves, T.
    Sangalho, I
    Neves, J.
    Brasileiro, A.
    Paiva, Lopes M. J.
    Leiria Pinto, P.
    ALLERGY, 2021, 76 : 233 - 233
  • [50] The use of Omalizumab in Severe Allergic Asthma and Chronic Spontaneous Urticaria: real-life experience
    Irani, Carla
    Hallit, Souheil
    Daccache, Stephanie
    Salameh, Pascale
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB34 - AB34
12345